Encompass Health CORP Form 4 insider transactions

Douglas E. Coltharp, EVP & Chief Financial Officer of Encompass Health Corp, reports acquisition of non-qualified stock options.

John Patrick Darby, EVP, Gen Counsel & Secretary of Encompass Health Corp, reports acquisition of stock options.

Encompass Health Corp's CEO, Mark J. Tarr, acquired 33,086 non-qualified stock options on March 4, 2025, exercisable in installments starting March 4, 2026.

Encompass Health's CEO, Mark Tarr, reports a transaction involving the withholding of shares to cover tax obligations related to restricted stock vesting.

Elissa Joy Charbonneau, Chief Medical Officer of Encompass Health Corp, sold 364 shares of common stock on February 28, 2025, to cover tax obligations related to vesting restricted stock.

Douglas Coltharp, EVP & Chief Financial Officer of Encompass Health Corp, reports changes in beneficial ownership of company stock due to tax withholding obligations and spousal holdings.

EVP, Gen Counsel & Secretary of Encompass Health Corp, John Patrick Darby, sold 416 shares of common stock to cover tax obligations arising from vesting restricted stock.

Edmund Fay, Sr. Vice President and Treasurer of Encompass Health Corp, reports disposition of 276 shares to cover tax obligations.

Andrew L. Price, Chief Accounting Officer of Encompass Health Corp, reports the disposal of 304 shares to cover tax obligations related to vesting restricted stock on February 28, 2025.

Elissa Joy Charbonneau, Chief Medical Officer of Encompass Health Corp, reports disposing of shares to cover tax withholding obligations.

John Patrick Darby, EVP, Gen Counsel & Secretary of Encompass Health Corp, reported disposing of shares to cover tax withholding obligations related to restricted stock vesting.

Encompass Health's CFO, Douglas Coltharp, disposed of shares to cover tax obligations related to vesting restricted stock, while also reporting holdings in trusts and by his spouse.

Edmund Fay, Sr. Vice President and Treasurer of Encompass Health Corp, reported disposing of shares to cover tax withholding obligations related to vesting restricted stock.

Encompass Health's CEO, Mark Tarr, disposed of shares to cover tax obligations related to the vesting of restricted stock.

Andrew L. Price, Chief Accounting Officer of Encompass Health Corp, reports disposing of shares to cover tax withholding obligations related to vesting restricted stock.

Encompass Health's EVP & Chief Financial Officer, Douglas Coltharp, reports acquisition of restricted stock and dispositions, along with holdings in irrevocable trusts and spousal ownership.

Edmund Fay, Sr. Vice President and Treasurer of Encompass Health Corp, reports acquiring 1,404 shares of restricted stock on February 20, 2025, as part of an annual award.

John Patrick Darby, EVP, Gen Counsel & Secretary of Encompass Health Corp, reports the acquisition of 2,216 shares of common stock on February 20, 2025, through an annual restricted stock award.

Elissa Joy Charbonneau, Chief Medical Officer of Encompass Health Corp, reports acquiring 1,939 shares of common stock as part of an annual restricted stock award.

Andrew L. Price, Chief Accounting Officer of Encompass Health Corp, acquired 1,538 shares of company stock on February 20, 2025, as part of an annual restricted stock award.

Encompass Health Corp's CEO, Mark J. Tarr, acquired 12,152 shares of common stock on February 20, 2025, as part of an annual restricted stock award.

Andrew L. Price, Chief Accounting Officer of Encompass Health Corp, sold 5,042 shares of common stock at an average price of $98.29 on February 13, 2025.

Terrance Williams, a director at Encompass Health Corp, acquired 25 additional shares of common stock through a dividend reinvestment program.

Director Nancy M. Schlichting acquired 36 shares of Encompass Health Corp stock through a dividend reinvestment program.

Director Christopher R. Reidy of Encompass Health Corp. reports acquiring shares through dividend reinvestment and a deferred stock plan.

Director Kevin J. O'Connor received 14 shares of Encompass Health stock through a dividend reinvestment program.

Patricia Anne Maryland, a director at Encompass Health Corp, received 25 restricted stock units (RSUs) due to a dividend payment.

Director Leslye G. Katz acquired 83 shares of Encompass Health Corp through a dividend reinvestment program.

Director Joan E. Herman acquired 83 shares of Encompass Health Corp stock through a dividend reinvestment program.

Director Greg D. Carmichael acquired 25 additional shares of Encompass Health Corp through a dividend reinvestment program.